CXXIF (C21 Investments) FCF Yield %: 3.58 (As of Jul. 03, 2026) — 32% Below Median


CXXIF C21 Investments Inc CXXIF
31 GF Score
Price $0.24
GF Value $0.28
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is C21 Investments FCF Yield %?

C21 Investments CXXIF +10.72% 31 FCF Yield % is 3.58 as of Jul. 03, 2026, which is 32% below its 10-year median of 5.27. GuruFocus rates CXXIF with a GF Score™ of 31/100 and a GF Value™ of $0.28 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 1,006 Drug Manufacturers companies, C21 Investments ranks better than 69.38% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, C21 Investments's Trailing 12-Month Free Cash Flow is $1.11 Mil, and Market Cap is $28.42 Mil. Therefore, C21 Investments's FCF Yield % for today is 3.58%.

The historical rank and industry rank for C21 Investments's FCF Yield % or its related term are showing as below:

CXXIF' s FCF Yield % Range Over the Past 10 Years
Min: -62.02   Med: 5.27   Max: 28.31
Current: 3.58


During the past 13 years, the highest FCF Yield % of C21 Investments was 28.31%. The lowest was -62.02%. And the median was 5.27%.

CXXIF's FCF Yield % is ranked better than
69.38% of 1006 companies
in the Drug Manufacturers industry
Industry Median: 0.665 vs CXXIF: 3.58

C21 Investments's FCF Margin % for the quarter that ended in Mar. 2026 was 3.50%.


C21 Investments FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


C21 Investments FCF Yield % Related Terms


C21 Investments FCF Yield % Historical Data

* Premium members only.

The historical data trend for C21 Investments's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

C21 Investments FCF Yield % Chart

C21 Investments Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Mar25 Mar26
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.91 17.79 5.85 -12.05 3.48

C21 Investments Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.37 8.99 4.32 -0.68 3.27

CXXIF vs ZTS, UTHR: FCF Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, C21 Investments's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C21 Investments FCF Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, C21 Investments's FCF Yield % distribution charts can be found below:

* The bar in red indicates where C21 Investments's FCF Yield % falls into.


CXXIF
31GF Score
C21 Investments Inc CXXIF
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

C21 Investments FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

C21 Investments's FCF Yield % for the fiscal year that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=1.11 / 31.933556
=3.48%

C21 Investments's annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=0.261 * 4 / 31.933556
=3.27%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of 3.58 mean?
C21 Investments (CXXIF) has a FCF Yield % of 3.58 as of Jul. 03, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on C21 Investments and its competitors. This is 32% below median its historical median of 5.27. According to the industry distribution chart, C21 Investments ranks #308 out of 1006 companies in the Drug Manufacturers industry, placing it in the top 30.6%.
Is C21 Investments' FCF Yield % too high?
C21 Investments' current FCF Yield % of 3.58 is 32% below median its 10-year median of 5.27. The Drug Manufacturers industry median FCF Yield % is 0.67. C21 Investments' value of 3.58 is 438.3% above this industry median. Based on the distribution chart, C21 Investments ranks #308 out of 1006 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, C21 Investments has a GF Score™ of 31/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does C21 Investments' FCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, C21 Investments ranks #308 out of 1006 companies for FCF Yield %. This puts C21 Investments in the upper half of its industry. The industry median FCF Yield % is 0.67. C21 Investments' value of 3.58 is 438.3% above this benchmark. While the company's 10-year median is 5.27 vs. the industry median of 0.67, C21 Investments has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.67, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. C21 Investments's current FCF Yield % of 3.58 is 438.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on C21 Investments and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. C21 Investments's current FCF Yield % is 3.58, which is 32% below median its own 10-year median of 5.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is C21 Investments stock overvalued right now?
Based on GuruFocus' analysis, C21 Investments (CXXIF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.28, compared to a current price of $0.24 — trading 13% below its estimated fair value. The current FCF Yield % is 3.58, which is 32% below median its 10-year median of 5.27 and 438.3% above the Drug Manufacturers industry median of 0.67. C21 Investments' overall GF Score™ is 31/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For C21 Investments (CXXIF), the current FCF Yield % is 3.58 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is C21 Investments (CXXIF) Overvalued in 2026?

Based on GuruFocus' analysis, C21 Investments stock appears to be undervalued. The current stock price of $0.24 is trading 13% below its estimated GF Value™ of $0.28. GuruFocus considers C21 Investments to be Modestly Undervalued.

Key valuation signals for CXXIF:

  • FCF Yield %: 3.58 (32% below median its 10-year median of 5.27)
  • GF Value™: $0.28 vs. price of $0.24 (13% below fair value)
  • GF Score™: 31/100 with 4 warning signs
  • Industry Position: 438.3% above the Drug Manufacturers median (#308 of 1006)

No single metric tells the full story. See the CXXIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


C21 Investments Business Description

Other Exchanges CXXI:Canada
Address 885 West Georgia Street, Floor 19, Vancouver, BC, CAN, V6C 3H4
C21 Investments Inc is a vertically integrated cannabis company that cultivates, processes, distributes, and sells quality cannabis and hemp-derived consumer products in Nevada, U.S.A., and the United States. The Company is focused on value creation through the disciplined acquisition and integration of core retail, manufacturing, and distribution assets in strategic markets, leveraging industry retail revenues with high-growth potential and multi-market branded consumer packaged goods (CPG). The Company focuses on scalable opportunities in key markets through retail operational excellence, expanding its retail footprint through value-add acquisitions in existing markets, and branded CPG expansion through captive retail and wholesale channels.
31GF Score

Get the complete analysis for CXXIF

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.24
Price
$0.28
GF Value